Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 22


Results: 14
    1

    KRAS inhibitors: going noncovalent.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 22, p. 3911, doi. 10.1002/1878-0261.13341
    By:
    • Drosten, Matthias;
    • Barbacid, Mariano
    Publication type:
    Article
    2
    3
    5
    6

    Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 22, p. 3949, doi. 10.1002/1878-0261.13322
    By:
    • Hariharan, Ananya;
    • Qi, Weihong;
    • Rehrauer, Hubert;
    • Wu, Licun;
    • Ronner, Manuel;
    • Wipplinger, Martin;
    • Kresoja‐Rakic, Jelena;
    • Sun, Suna;
    • Oton‐Gonzalez, Lucia;
    • Sculco, Marika;
    • Serre‐Beinier, Véronique;
    • Meiller, Clément;
    • Blanquart, Christophe;
    • Fonteneau, Jean‐François;
    • Vrugt, Bart;
    • Rüschoff, Jan Hendrik;
    • Opitz, Isabelle;
    • Jean, Didier;
    • de Perrot, Marc;
    • Felley‐Bosco, Emanuela
    Publication type:
    Article
    7
    8
    9
    10

    Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 22, p. 3994, doi. 10.1002/1878-0261.13314
    By:
    • Yoshikawa, Yuki;
    • Stopsack, Konrad H.;
    • Wang, Xin Victoria;
    • Chen, Yu‐Hui;
    • Mazzu, Ying Z.;
    • Burton, Foster;
    • Chakraborty, Goutam;
    • Rajanala, Sai Harisha;
    • Hirani, Rahim;
    • Nandakumar, Subhiksha;
    • Lee, Gwo‐Shu Mary;
    • Frank, David;
    • Davicioni, Elai;
    • Liu, Glenn;
    • Carducci, Michael A.;
    • Azuma, Haruhito;
    • Kantoff, Philip W.;
    • Sweeney, Christopher J.
    Publication type:
    Article
    11
    12
    13
    14

    Issue Information.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 22, p. 3909, doi. 10.1002/1878-0261.13009
    Publication type:
    Article